INTRODUCTION AND OBJECTIVE: Readmission rates after radical cystectomy are among the highest of any surgery. The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals with excess readmissions for certain targeted conditions, including total hip and knee arthroplasty. We examined whether changes made by hospitals in response to the HRRP had spillover effects on radical cystectomy readmissions. METHODS: We used a 20% sample of Medicare data to identify patients undergoing cystectomy from 2010 to 2014 and measured 30-day adjusted cystectomy readmission rates. To determine the effect of the HRRP, we calculated adjusted readmission rates following total hip or knee arthroplasty and stratified hospitals into quartiles (most improved, middle quartiles, least improved) based on their improvement in reducing those targeted readmissions. Multivariable logistic regression was used to identify factors associated with spillover effects from the targeted joint surgery to cystectomy. RESULTS: We identified 2,394 patients undergoing radical cystectomy. Of these, 606 were treated at hospitals in the "most improved" quartile and 522 in the "least improved." Patients undergoing cystectomy were similar in age, comorbidity, and SEC independent of hospital performance quartile. The readmission rate following cystectomy was 26% in the most improved quartile and 24% in the least improved. No spillover effect was identified between readmission reduction after major joint surgery and radical cystectomy (adjusted OR 0.90, p=0.42). CONCLUSIONS: Hospitals that succeeded in reducing readmissions following major joint surgery targeted by the HRRP did not have similar reductions in readmissions following radical cystectomy. This lack of spillover effect suggests that each surgical condition may require tailored interventions to prevent readmissions.
INTRODUCTION AND OBJECTIVE: Readmission rates after radical cystectomy are among the highest of any surgery. The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals with excess readmissions for certain targeted conditions, including total hip and knee arthroplasty. We examined whether changes made by hospitals in response to the HRRP had spillover effects on radical cystectomy readmissions. METHODS: We used a 20% sample of Medicare data to identify patients undergoing cystectomy from 2010 to 2014 and measured 30-day adjusted cystectomy readmission rates. To determine the effect of the HRRP, we calculated adjusted readmission rates following total hip or knee arthroplasty and stratified hospitals into quartiles (most improved, middle quartiles, least improved) based on their improvement in reducing those targeted readmissions. Multivariable logistic regression was used to identify factors associated with spillover effects from the targeted joint surgery to cystectomy. RESULTS: We identified 2,394 patients undergoing radical cystectomy. Of these, 606 were treated at hospitals in the "most improved" quartile and 522 in the "least improved." Patients undergoing cystectomy were similar in age, comorbidity, and SEC independent of hospital performance quartile. The readmission rate following cystectomy was 26% in the most improved quartile and 24% in the least improved. No spillover effect was identified between readmission reduction after major joint surgery and radical cystectomy (adjusted OR 0.90, p=0.42). CONCLUSIONS: Hospitals that succeeded in reducing readmissions following major joint surgery targeted by the HRRP did not have similar reductions in readmissions following radical cystectomy. This lack of spillover effect suggests that each surgical condition may require tailored interventions to prevent readmissions.
Authors: Paul Feigenbaum; Estee Neuwirth; Linda Trowbridge; Serge Teplitsky; Carol Ann Barnes; Emily Fireman; Jann Dorman; Jim Bellows Journal: Med Care Date: 2012-07 Impact factor: 2.983
Authors: Tudor Borza; Bruce L Jacobs; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Khaled S Hafez; Cheryl T Lee; Benjamin Y Li; Hye Sung Min; Chang He; Scott M Gilbert; Jonathan E Helm; Mariel S Lavieri; Brent K Hollenbeck; Ted A Skolarus Journal: Urology Date: 2017-03-04 Impact factor: 2.649
Authors: Vignesh T Packiam; Vijay A Agrawal; Joseph J Pariser; Andrew J Cohen; Charles U Nottingham; Shane M Pearce; Norm D Smith; Gary D Steinberg Journal: World J Urol Date: 2016-07-30 Impact factor: 4.226
Authors: Ted A Skolarus; Bruce L Jacobs; Florian R Schroeck; Chang He; Alexander M Helfand; Jonathan Helm; Michael Hu; Mariel Lavieri; Brent K Hollenbeck Journal: J Urol Date: 2014-11-04 Impact factor: 7.450
Authors: A V Diez Roux; S S Merkin; D Arnett; L Chambless; M Massing; F J Nieto; P Sorlie; M Szklo; H A Tyroler; R L Watson Journal: N Engl J Med Date: 2001-07-12 Impact factor: 91.245
Authors: Teresa L Kauf; Robert S Svatek; Gilad Amiel; Timothy L Beard; Sam S Chang; Amr Fergany; R Jeffrey Karnes; Michael Koch; Jerome O'Hara; Cheryl T Lee; Wade J Sexton; Joel W Slaton; Gary D Steinberg; Shandra S Wilson; Lee Techner; Carolyn Martin; Jessica Moreno; Ashish M Kamat Journal: J Urol Date: 2013-12-14 Impact factor: 7.450
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004